Biodexa Pharmaceuticals Plc (BDRX) SEC Filings & Financial Intelligence
Biodexa Pharmaceuticals Plc (BDRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BDRX
CIK: 1643918
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PKF Littlejohn LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDavid Thompson
Audit LocationLondon, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-14 | 2026-10-14 | FORM 6-K | 0001171843-26-006616 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | 333-279994 | 0001214659-26-012866 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | PROSPECTUS SUPPLEMENT NO. 5 | 0001214659-26-012864 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | 333-297473 | 0001214659-26-012870 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | 333-284350 PROSPECTUS SUPPLEMENT NO. 5 | 0001214659-26-012868 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | PROSPECTUS SUPPLEMENT NO. 5 | 0001214659-26-012869 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | 333-281489 | 0001214659-26-012867 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | PROSPECTUS SUPPLEMENT NO. 5 | 0001214659-26-012865 | View SEC Doc Filr Page |
| 424B3 | 2026-10-14 | — | 333-299106 | 0001214659-26-012871 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-10-08 | 6-K Filing | 0001214659-26-012706 | View SEC Doc Filr Page |
| 424B3 | 2026-10-06 | — | 424B3 Filing | 0001214659-26-012602 | View SEC Doc Filr Page |
| EFFECT | 2026-09-30 | — | EFFECT Filing | 9999999995-26-003123 | View SEC Doc Filr Page |
| F-1 | 2026-09-24 | — | WARRANT INDUCEMENT | 0001214659-26-011934 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011695 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011693 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011689 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011694 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011692 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011691 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 Filing | 0001214659-26-011690 | View SEC Doc Filr Page |
| 6-K | 2026-09-15 | 2026-09-15 | 6-K Filing | 0001214659-26-011688 | View SEC Doc Filr Page |
| 424B3 | 2026-09-11 | — | 424B3 Filing | 0001214659-26-011637 | View SEC Doc Filr Page |
| 424B3 | 2026-09-11 | — | 424B3 Filing | 0001214659-26-011634 | View SEC Doc Filr Page |
| 424B3 | 2026-09-11 | — | 424B3 Filing | 0001214659-26-011633 | View SEC Doc Filr Page |
| 424B3 | 2026-09-11 | — | 424B3 Filing | 0001214659-26-011632 | View SEC Doc Filr Page |